Kulshreshtha Nishant Nitinidhi, Barthélémy Philippe
Department of Biology, Indian Institute of Science Education and Research Pune 411008 India
ARNA, INSERM U1212, CNRS 5320, Université de Bordeaux Bordeaux F-33076 France
RSC Med Chem. 2025 Apr 17. doi: 10.1039/d5md00142k.
G quadruplexes are secondary structures formed by G-rich sequences in DNA/RNA. They are critical regulatory centres for gene activation and chromosome stability. Malfunctions in their number or topology often results in ailments such as frontotemporal dementia, amyotrophic lateral sclerosis, coronary heart disease, anaemia, and various cancers. Proteins and ligands can bind to them only if the quadruplex topology matches their requirements. Hence, stabilizing or destabilizing this topology can have profound implications in therapeutics. Novel nucleic acid modalities involving intra-conjugated G4s are an interesting prospect as they have a fixed topology without the use of additional ligand stabilizers. They could also efficiently bind to G4-associated proteins and have important consequences in clinical research and development. In this opinion, a justification for the development of these modalities is presented by highlighting their advantages and the potential applications that can be unlocked by locking G4 sequences.
G-四链体是由DNA/RNA中富含鸟嘌呤(G)的序列形成的二级结构。它们是基因激活和染色体稳定性的关键调控中心。其数量或拓扑结构的异常通常会导致诸如额颞叶痴呆、肌萎缩侧索硬化症、冠心病、贫血和各种癌症等疾病。只有当四链体拓扑结构符合其要求时,蛋白质和配体才能与之结合。因此,稳定或破坏这种拓扑结构在治疗方面可能具有深远意义。涉及内共轭G4的新型核酸形式是一个有趣的研究方向,因为它们具有固定的拓扑结构,无需额外的配体稳定剂。它们还可以有效地结合与G4相关的蛋白质,并在临床研究和开发中产生重要影响。在本观点中,通过强调这些形式的优势以及锁定G4序列可实现的潜在应用,为其开发提供了正当理由。